Osman Gani

835 total citations
22 papers, 570 citations indexed

About

Osman Gani is a scholar working on Molecular Biology, Organic Chemistry and Biochemistry. According to data from OpenAlex, Osman Gani has authored 22 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Biochemistry. Recurrent topics in Osman Gani's work include Eicosanoids and Hypertension Pharmacology (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Click Chemistry and Applications (3 papers). Osman Gani is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Click Chemistry and Applications (3 papers). Osman Gani collaborates with scholars based in Norway, United States and United Kingdom. Osman Gani's co-authors include Richard A. Engh, Ingebrigt Sylte, Sylvie Ducki, Trond Vidar Hansen, Kristin Odlo, Viví Ann Flørenes, Jérémie Fournier Dit Chabert, Martina L. Skrede, Adele Williamson and Ronny Helland and has published in prestigious journals such as Bioinformatics, Scientific Reports and Biophysical Journal.

In The Last Decade

Osman Gani

21 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osman Gani Norway 9 257 222 66 55 40 22 570
Figueroa‐Valverde Lauro Mexico 13 175 0.7× 185 0.8× 43 0.7× 22 0.4× 52 1.3× 127 632
Monika Chauhan India 11 328 1.3× 227 1.0× 39 0.6× 17 0.3× 50 1.3× 42 631
Huiqiang Zhou United States 14 200 0.8× 309 1.4× 30 0.5× 57 1.0× 52 1.3× 21 540
Rubén Alvarez‐Sánchez Switzerland 15 94 0.4× 294 1.3× 33 0.5× 26 0.5× 104 2.6× 24 728
Kamel Metwally Egypt 15 304 1.2× 227 1.0× 108 1.6× 13 0.2× 51 1.3× 39 728
Li‐Qiang Sun United States 16 413 1.6× 320 1.4× 102 1.5× 11 0.2× 36 0.9× 40 873
Mayumi Shikano Japan 9 105 0.4× 136 0.6× 93 1.4× 91 1.7× 20 0.5× 33 404
H. Rüeger Switzerland 11 254 1.0× 435 2.0× 58 0.9× 32 0.6× 40 1.0× 17 841
Hee Jeong Seo South Korea 15 234 0.9× 192 0.9× 109 1.7× 46 0.8× 27 0.7× 26 531
Rasha A. Nassra Egypt 14 314 1.2× 183 0.8× 133 2.0× 16 0.3× 29 0.7× 31 623

Countries citing papers authored by Osman Gani

Since Specialization
Citations

This map shows the geographic impact of Osman Gani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osman Gani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osman Gani more than expected).

Fields of papers citing papers by Osman Gani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osman Gani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osman Gani. The network helps show where Osman Gani may publish in the future.

Co-authorship network of co-authors of Osman Gani

This figure shows the co-authorship network connecting the top 25 collaborators of Osman Gani. A scholar is included among the top collaborators of Osman Gani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osman Gani. Osman Gani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nolsøe, Jens M. J., Jarl Underhaug, Karl Egil Malterud, et al.. (2024). Biological Evaluations, NMR Analyses, Molecular Modeling Studies, and Overview of the Synthesis of the Marine Natural Product (−)-Mucosin. Molecules. 29(5). 994–994. 1 indexed citations
3.
Rødevand, Linn, Shahram Bahrami, Oleksandr Frei, et al.. (2021). Polygenic overlap and shared genetic loci between loneliness, severe mental disorders, and cardiovascular disease risk factors suggest shared molecular mechanisms. Translational Psychiatry. 11(1). 3–3. 38 indexed citations
4.
Gani, Osman, et al.. (2021). Types of Abortion and Its Consequences in Dhaka Medical College Hospital. 10(1-2). 66–73.
5.
Shadrin, Alexey, Oleksandr Frei, Olav B. Smeland, et al.. (2020). Phenotype-specific differences in polygenicity and effect size distribution across functional annotation categories revealed by AI-MiXeR. Bioinformatics. 36(18). 4749–4756. 6 indexed citations
7.
Alam, Mohammad Zahedul, Wang Hu, & Osman Gani. (2019). An Empirical Analysis of the Influencing Factors of Adoption of Mobile Health Services in Bangladesh Based on Extended UTAUT Model. Journal of the Association for Information Systems. 4 indexed citations
8.
Santi, Concetta De, Osman Gani, Ronny Helland, & Adele Williamson. (2017). Structural insight into a CE15 esterase from the marine bacterial metagenome. Scientific Reports. 7(1). 17278–17278. 19 indexed citations
9.
Gani, Osman, et al.. (2017). Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR. Journal of Cheminformatics. 9(1). 43–43. 3 indexed citations
10.
Gani, Osman. (2017). A Novel Approach to Complex Human Activity Recognition. e-Publications@Marquette (Marquette University). 4 indexed citations
11.
Gani, Osman, et al.. (2013). Evaluating the Predictivity of Virtual Screening for Abl Kinase Inhibitors to Hinder Drug Resistance. Chemical Biology & Drug Design. 82(5). 506–519. 7 indexed citations
12.
Pflug, A., et al.. (2012). Structural origins of AGC protein kinase inhibitor selectivities: PKA as a drug discovery tool. Biological Chemistry. 393(10). 1121–1129. 7 indexed citations
13.
Gani, Osman & Richard A. Engh. (2010). Protein kinase inhibition of clinically important staurosporine analogues. Natural Product Reports. 27(4). 489–489. 111 indexed citations
14.
Odlo, Kristin, et al.. (2010). 1,2,3-Triazole analogs of combretastatin A-4 as potential microtubule-binding agents. Bioorganic & Medicinal Chemistry. 18(18). 6874–6885. 77 indexed citations
15.
Gani, Osman & Ingebrigt Sylte. (2008). Molecular recognition of Docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor α. Journal of Molecular Graphics and Modelling. 27(2). 217–224. 43 indexed citations
16.
Odlo, Kristin, Jérémie Fournier Dit Chabert, Sylvie Ducki, et al.. (2008). 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin. Bioorganic & Medicinal Chemistry. 16(9). 4829–4838. 158 indexed citations
17.
Gani, Osman & Ingebrigt Sylte. (2008). Ligand‐Induced Stabilization and Activation of Peroxisome Proliferator‐Activated Receptor γ. Chemical Biology & Drug Design. 72(1). 50–57. 6 indexed citations
18.
Gani, Osman. (2008). Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?. Cardiovascular Diabetology. 7(1). 6–6. 45 indexed citations
19.
Gani, Osman, Olayiwola A. Adekoya, Francesca Spyrakis, et al.. (2007). Theoretical Calculations of the Catalytic Triad in Short-Chain Alcohol Dehydrogenases/Reductases. Biophysical Journal. 94(4). 1412–1427. 23 indexed citations
20.
Gani, Osman. (2007). Signposts of Docking and Scoring in Drug Design. Chemical Biology & Drug Design. 70(4). 360–365. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026